KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 78 filers reported holding KEZAR LIFE SCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,648,157 | -50.0% | 1,385,006 | +3.0% | 0.00% | -100.0% |
Q2 2023 | $3,295,164 | -2.7% | 1,344,965 | +24.3% | 0.00% | 0.0% |
Q1 2023 | $3,386,960 | +6.1% | 1,082,096 | +138.7% | 0.00% | 0.0% |
Q4 2022 | $3,190,937 | -61.1% | 453,258 | -52.5% | 0.00% | -50.0% |
Q3 2022 | $8,210,000 | +45.4% | 953,592 | +39.7% | 0.00% | +100.0% |
Q2 2022 | $5,645,000 | +31.1% | 682,572 | +163.3% | 0.00% | 0.0% |
Q1 2022 | $4,307,000 | +198.9% | 259,195 | +200.7% | 0.00% | – |
Q4 2021 | $1,441,000 | -39.1% | 86,202 | -68.5% | 0.00% | -100.0% |
Q3 2021 | $2,365,000 | +273.6% | 273,741 | +134.9% | 0.00% | – |
Q2 2021 | $633,000 | +4.8% | 116,555 | +15.0% | 0.00% | – |
Q1 2021 | $604,000 | +30.7% | 101,347 | +14.3% | 0.00% | – |
Q4 2020 | $462,000 | +28.3% | 88,648 | +19.0% | 0.00% | – |
Q3 2020 | $360,000 | +28.6% | 74,494 | +37.9% | 0.00% | – |
Q2 2020 | $280,000 | +221.8% | 54,018 | +172.0% | 0.00% | – |
Q1 2020 | $87,000 | +17.6% | 19,857 | +8.1% | 0.00% | – |
Q4 2019 | $74,000 | -48.3% | 18,374 | -57.9% | 0.00% | – |
Q3 2019 | $143,000 | +27.7% | 43,674 | +199.9% | 0.00% | – |
Q2 2019 | $112,000 | -74.1% | 14,565 | -41.7% | 0.00% | – |
Q2 2018 | $433,000 | – | 25,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 3,200,000 | $10,016,000 | 4.75% |
Qiming U.S. Ventures Management, LLC | 828,711 | $2,593,865 | 3.14% |
SPHERA FUNDS MANAGEMENT LTD. | 1,888,228 | $5,910,154 | 0.99% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 6,887,591 | $21,558,160 | 0.91% |
Avidity Partners Management LP | 6,519,400 | $20,405,722 | 0.68% |
Ikarian Capital, LLC | 841,596 | $2,634,195 | 0.60% |
Opaleye Management Inc. | 625,000 | $1,956,250 | 0.59% |
CHI Advisors LLC | 689,451 | $2,157,982 | 0.57% |
Orbimed Advisors | 5,463,000 | $17,099,190 | 0.34% |
Palo Alto Investors LP | 656,200 | $2,053,906 | 0.17% |